239 related articles for article (PubMed ID: 16228196)
1. Effects of ketamine on prefrontal and striatal regions in an overt verbal fluency task: a functional magnetic resonance imaging study.
Fu CH; Abel KM; Allin MP; Gasston D; Costafreda SG; Suckling J; Williams SC; McGuire PK
Psychopharmacology (Berl); 2005 Nov; 183(1):92-102. PubMed ID: 16228196
[TBL] [Abstract][Full Text] [Related]
2. Neural correlates of S-ketamine induced psychosis during overt continuous verbal fluency.
Nagels A; Kirner-Veselinovic A; Krach S; Kircher T
Neuroimage; 2011 Jan; 54(2):1307-14. PubMed ID: 20727411
[TBL] [Abstract][Full Text] [Related]
3. Effects of ketamine-induced psychopathological symptoms on continuous overt rhyme fluency.
Nagels A; Kirner-Veselinovic A; Wiese R; Paulus FM; Kircher T; Krach S
Eur Arch Psychiatry Clin Neurosci; 2012 Aug; 262(5):403-14. PubMed ID: 22189657
[TBL] [Abstract][Full Text] [Related]
4. [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine].
Mechri A; Saoud M; Khiari G; d'Amato T; Dalery J; Gaha L
Encephale; 2001; 27(1):53-9. PubMed ID: 11294039
[TBL] [Abstract][Full Text] [Related]
5. Effects of psychotic state and task demand on prefrontal function in schizophrenia: an fMRI study of overt verbal fluency.
Fu CH; Suckling J; Williams SC; Andrew CM; Vythelingum GN; McGuire PK
Am J Psychiatry; 2005 Mar; 162(3):485-94. PubMed ID: 15741465
[TBL] [Abstract][Full Text] [Related]
6. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
Krystal JH; Karper LP; Seibyl JP; Freeman GK; Delaney R; Bremner JD; Heninger GR; Bowers MB; Charney DS
Arch Gen Psychiatry; 1994 Mar; 51(3):199-214. PubMed ID: 8122957
[TBL] [Abstract][Full Text] [Related]
7. Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia.
Kegeles LS; Abi-Dargham A; Zea-Ponce Y; Rodenhiser-Hill J; Mann JJ; Van Heertum RL; Cooper TB; Carlsson A; Laruelle M
Biol Psychiatry; 2000 Oct; 48(7):627-40. PubMed ID: 11032974
[TBL] [Abstract][Full Text] [Related]
8. Selective augmentation of striatal functional connectivity following NMDA receptor antagonism: implications for psychosis.
Dandash O; Harrison BJ; Adapa R; Gaillard R; Giorlando F; Wood SJ; Fletcher PC; Fornito A
Neuropsychopharmacology; 2015 Feb; 40(3):622-31. PubMed ID: 25141922
[TBL] [Abstract][Full Text] [Related]
9. Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function.
Krystal JH; Perry EB; Gueorguieva R; Belger A; Madonick SH; Abi-Dargham A; Cooper TB; Macdougall L; Abi-Saab W; D'Souza DC
Arch Gen Psychiatry; 2005 Sep; 62(9):985-94. PubMed ID: 16143730
[TBL] [Abstract][Full Text] [Related]
10. Selective cognitive impairments associated with NMDA receptor blockade in humans.
Rowland LM; Astur RS; Jung RE; Bustillo JR; Lauriello J; Yeo RA
Neuropsychopharmacology; 2005 Mar; 30(3):633-9. PubMed ID: 15647751
[TBL] [Abstract][Full Text] [Related]
11. Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy: a [(123)I]CNS-1261 SPET study.
Stone JM; Erlandsson K; Arstad E; Squassante L; Teneggi V; Bressan RA; Krystal JH; Ell PJ; Pilowsky LS
Psychopharmacology (Berl); 2008 Apr; 197(3):401-8. PubMed ID: 18176855
[TBL] [Abstract][Full Text] [Related]
12. Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study.
Deakin JF; Lees J; McKie S; Hallak JE; Williams SR; Dursun SM
Arch Gen Psychiatry; 2008 Feb; 65(2):154-64. PubMed ID: 18250253
[TBL] [Abstract][Full Text] [Related]
13. Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers.
Breier A; Malhotra AK; Pinals DA; Weisenfeld NI; Pickar D
Am J Psychiatry; 1997 Jun; 154(6):805-11. PubMed ID: 9167508
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of ketamine effects by nimodipine pretreatment in recovering ethanol dependent men: psychopharmacologic implications of the interaction of NMDA and L-type calcium channel antagonists.
Krupitsky EM; Burakov AM; Romanova TN; Grinenko NI; Grinenko AY; Fletcher J; Petrakis IL; Krystal JH
Neuropsychopharmacology; 2001 Dec; 25(6):936-47. PubMed ID: 11750186
[TBL] [Abstract][Full Text] [Related]
15. NMDA hypofunction in the posterior cingulate as a model for schizophrenia: an exploratory ketamine administration study in fMRI.
Northoff G; Richter A; Bermpohl F; Grimm S; Martin E; Marcar VL; Wahl C; Hell D; Boeker H
Schizophr Res; 2005 Jan; 72(2-3):235-48. PubMed ID: 15560968
[TBL] [Abstract][Full Text] [Related]
16. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.
Javitt DC
Int Rev Neurobiol; 2007; 78():69-108. PubMed ID: 17349858
[TBL] [Abstract][Full Text] [Related]
17. The effects of a subanesthetic dose of ketamine on verbal memory in normal volunteers.
Parwani A; Weiler MA; Blaxton TA; Warfel D; Hardin M; Frey K; Lahti AC
Psychopharmacology (Berl); 2005 Dec; 183(3):265-74. PubMed ID: 16220331
[TBL] [Abstract][Full Text] [Related]
18. S-Ketamine-Induced NMDA Receptor Blockade during Natural Speech Production and Its Implications for Formal Thought Disorder in Schizophrenia: A Pharmaco-fMRI Study.
Nagels A; Cabanis M; Oppel A; Kirner-Veselinovic A; Schales C; Kircher T
Neuropsychopharmacology; 2018 May; 43(6):1324-1333. PubMed ID: 29105665
[TBL] [Abstract][Full Text] [Related]
19. Ketamine increases striatal dopamine release and hyperlocomotion in adult rats after postnatal functional blockade of the prefrontal cortex.
Usun Y; Eybrard S; Meyer F; Louilot A
Behav Brain Res; 2013 Nov; 256():229-37. PubMed ID: 23958806
[TBL] [Abstract][Full Text] [Related]
20. N-methyl-d-aspartate receptor antagonist ketamine impairs action-monitoring activity in the prefrontal cortex.
Skoblenick K; Everling S
J Cogn Neurosci; 2014 Mar; 26(3):577-92. PubMed ID: 24188365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
